Abstract:Surface features are key to the transcellular transport of nanoparticles (NPs) across intestinal epithelium cells. Endowing the NPs with specific surface features adapted to the physiological conditions of the gastrointestinal (GI) tract holds great potential for the oral delivery of peptide/protein drugs. Therefore, in this work, a glutamic acid conjugated amphiphilic dendrimer (Glu-APD) was synthesized to replace the widely used 1,2-distearoyl-sn-glycero-3-phosphatidyl-ethanolamine-polyethylene glycol (DSPE-PEG) in the preparation of poly(lactic-co-glycolic acid) (PLGA)-based NPs. Glu-APD could provide the formed NPs (Glu-APD NPs) with specific surface features of dendritic oligopeptides. With such surface features, Glu-APD NPs exhibited a 7.78-fold increase in cellular uptake and a 2.17-fold increase in the transepithelial transport amount compared with those of the DSPE-PEG2000 modified counterparts (P NPs). Instead of a dominant clathrin-mediated endocytosis as shown by P NPs, Glu-APD can provide the NPs with optional endocytosis pathways (i.e. clathrin-mediated, caveolae-mediated and micropinocytosis pathways), with the involvement of oligopeptide transporters and amino acid transporters, subsequently leading to a broadened intracellular trafficking route via the endoplasmic reticulum (ER) and Golgi apparatus. Furthermore, l-glutamic acid (l-Glu), a natural nutrient, could specifically facilitate the exocytosis of Glu-APD NPs, indicating an amino-acid-associated intracellular trafficking. Oral administration of insulin-loaded Glu-APD NPs could also achieve a good hypoglycemic effect with a relative bioavailability of 10.04%, which is 1.89-fold higher than that of P NPs and 5.20-fold higher than insulin solution. Safety evaluations further verified the biocompatibility of Glu-APD NPs and the related materials. The results confirmed the feasibility of introducing Glu-APD to NPs for improving the oral delivery of insulin. With the surface features of dendritic peptide, Glu-APD could facilitate oligopeptide/amino-acid-associated transport of the related NPs, which might be considered as an advantage under physiological conditions. This work might also be considered as a valid reference for the construction of highly efficient oral delivery systems.

Systematic Evaluation of the Toxicity and Biodistribution of Virus Mimicking Mucus-Penetrating DLPC-NPs As Oral Drug Delivery System.

Sub‐50 Nm Nanoparticles with Biomimetic Surfaces to Sequentially Overcome the Mucosal Diffusion Barrier and the Epithelial Absorption Barrier

Effects of surface hydrophilic properties of PEG-based mucus-penetrating nanostructured lipid carriers on oral drug delivery

Lipid Nanovehicles with Adjustable Surface Properties for Overcoming Multiple Barriers Simultaneously in Oral Administration.

Enhanced Oral Delivery of Protein Drugs Using Zwitterion-Functionalized Nanoparticles to Overcome Both the Diffusion and Absorption Barriers

Functional lipid polymeric nanoparticles for oral drug delivery: Rapid mucus penetration and improved cell entry and cellular transport

A Strategy for Developing Effective Orally-Delivered Nanoparticles Through Modulation of the Surface "hydrophilicity/hydrophobicity Balance".

Nanoparticles exhibiting virus-mimic surface topology for enhanced oral delivery

Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide

Biocompatibility Assessment of Polyethylene Glycol-Poly L-Lysine-Poly Lactic-Co-Glycolic Acid Nanoparticles in Vitro and in Vivo

Biomimetic Viruslike and Charge Reversible Nanoparticles to Sequentially Overcome Mucus and Epithelial Barriers for Oral Insulin Delivery.

A Systematic Safety Evaluation of Nanoporous Mannitol Material As a Dry-Powder Inhalation Carrier System.

Nanoparticles with surface features of dendritic oligopeptides as potential oral drug delivery systems

Research on the fate of polymeric nanoparticles in the process of the intestinal absorption based on model nanoparticles with various characteristics: size, surface charge and pro-hydrophobics

Engineered Lipid Liquid Crystalline Nanoparticles As an Inhaled Nanoplatform for Mucus Penetration Enhancement

Engineering Nanomaterials to Overcome the Mucosal Barrier by Modulating Surface Properties

Multifunctional Nanoparticles Enable Efficient Oral Delivery of Biomacromolecules Via Improving Payload Stability and Regulating the Transcytosis Pathway.

Rapid transport of deformation-tuned nanoparticles across biological hydrogels and cellular barriers

Enhanced Transport of Shape and Rigidity-Tuned Α-Lactalbumin Nanotubes Across Intestinal Mucus and Cellular Barriers

Impact of physicochemical properties on biological effects of lipid nanoparticles: Are they completely safe

Ph-Responsive Mucus-Penetrating Nanoparticles for Enhanced Cellular Internalization by Local Administration in Vaginal Tissue.